Gruber R et al. |
Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/RANKL-dependent mechanism. |
2002 |
Bone |
pmid:11996911
|
de Hooge AS et al. |
Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. |
2002 |
Am. J. Pathol. |
pmid:12000725
|
Bosshart H |
Expression of survival receptors in Hodgkin disease cell lines. |
2002 |
Blood |
pmid:12001908
|
Ono K et al. |
Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. |
2002 |
J. Bone Miner. Res. |
pmid:12009007
|
Iida-Klein A et al. |
Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. |
2002 |
J. Bone Miner. Res. |
pmid:12009011
|
Jiang Y et al. |
Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. |
2002 |
Infect. Immun. |
pmid:12011008
|
Granchi D et al. |
Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. |
2002 |
Biomaterials |
pmid:12013183
|
Li X et al. |
Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo. |
2002 |
Prostaglandins Other Lipid Mediat. |
pmid:12013525
|
Treuheit MJ et al. |
Inverse relationship of protein concentration and aggregation. |
2002 |
Pharm. Res. |
pmid:12033388
|
Lossdörfer S et al. |
Immunohistochemical localization of receptor activator of nuclear factor kappaB (RANK) and its ligand (RANKL) in human deciduous teeth. |
2002 |
Calcif. Tissue Int. |
pmid:12043011
|
Ueland T et al. |
Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12050246
|
Sasaki N et al. |
Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. |
2002 |
Bone |
pmid:12052453
|
Brändström H et al. |
A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12054556
|
Wittrant Y et al. |
Osteoprotegerin differentially regulates protease expression in osteoclast cultures. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12054560
|
Penno H et al. |
Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12054622
|
Fu M et al. |
Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12056809
|
Zhang J et al. |
PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. |
2002 |
FEBS Lett. |
pmid:12067713
|
Nakamura H et al. |
Localization of osteoprotegerin (OPG) on bone surfaces and cement lines in rat tibia. |
2002 |
J. Histochem. Cytochem. |
pmid:12070273
|
Wynne F et al. |
Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. |
2002 |
Calcif. Tissue Int. |
pmid:12073153
|
Kim YH et al. |
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. |
2002 |
Exp. Mol. Med. |
pmid:12085990
|